Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine Among Older and Frail Patients With Advanced Gastroesophageal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer: The GO2 Phase 3 Randomized Clinical Trial
JAMA Oncol 2021 May 13;[EPub Ahead of Print], PS Hall, D Swinson, DA Cairns, JS Waters, R Petty, C Allmark, S Ruddock, S Falk, J Wadsley, R Roy, T Tillett, J Nicoll, S Cummins, J Mano, S Grumett, Z Stokes, K Konstantinos-Velios, A Chatterjee, A Garcia, T Waddell, K Guptal, N Maisey, M Khan, J Dent, S Lord, A Crossley, E Katona, H Marshall, HI Grabsch, G Velikova, PL Ow, C Handforth, H Howard, MT SeymourFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.